Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Chronic Hand Eczema
Interventions
DRUG

ARQ-252 cream 0.3%

ARQ-252 cream 0.3%

DRUG

ARQ-252 cream 0.1%

ARQ-252 cream 0.1%

DRUG

ARQ-252 Vehicle Cream

ARQ-252 Vehicle Cream

Trial Locations (37)

2145

Arcutis Clinical Site 306, Westmead

3002

Arcutis Clinical Site 303, East Melbourne

10029

Arcutis Clinical Site 171, New York

15213

Arcutis Clinical Site 135, Pittsburgh

20850

Arcutis Clinical Site 125, Rockville

23502

Arcutis Clinical Site 169, Norfolk

27262

Arcutis Clinical Site 115, High Point

32771

Arcutis Clinical Site 104, Sanford

33134

Arcutis Clinical Site 167, Coral Gables

33180

Arcutis Clinical Site 174, Aventura

40217

Arcutis Clinical Site 217, Louisville

46250

Arcutis Clinical Site 214, Indianapolis

48202

Arcutis Clinical Site 212, Detroit

55112

Arcutis Clinical Site 216, New Brighton

70006

Arcutis Clinical Site 213, Metairie

77056

Arcutis Clinical Site 164, Houston

77845

Arcutis Clinical Site 104, College Station

78213

Arcutis Clinical Site 161, San Antonio

78218

Arcutis Clinical Site 110, San Antonio

78660

Arcutis Clinical Site 163, Pflugerville

78759

Arcutis Clinical Site 162, Austin

90212

Arcutis Clinical Site 239, Beverly Hills

90404

Arcutis Clinical Site 208, Santa Monica

91436

Arcutis Clinical Site 225, Encino

92797

Arcutis Clinical Site 120, Irvine

94538

Arcutis Clinical Site 112, Fremont

97210

Arcutis Clinical Site 173, Portland

Unknown

Arcutis Clinical Site 207, Surrey

Arcutis Clinical Site 205, Ajax

Arcutis Clinical Site 218, Barrie

Arcutis Clinical Site 103, London

Arcutis Clinical Site 133, Mississauga

Arcutis Clinical Site 165, Oakville

Arcutis Clinical Site 109, Peterborough

Arcutis Clinical Site 241, Richmond Hill

Arcutis Clinical Site 106, Waterloo

Arcutis Clinical Site 242, Montreal

Sponsors
All Listed Sponsors
lead

Arcutis Biotherapeutics, Inc.

INDUSTRY

NCT04378569 - Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema | Biotech Hunter | Biotech Hunter